Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

11201
1
CYTOKINETICS INC Cytokinetics Reports Significant Revenue Growth, Widened Losses in Latest Quarter

Via official filing (AI summary) | 7 months ago | 0 comments

11202
1
GERON CORP Geron Corporation Reports Significant Revenue Growth, Net Loss in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11203
1
Phathom Pharmaceuticals, Inc. Phathom Pharmaceuticals Reports Revenue Growth, Net Loss in Q3 2024, Amid Strategic Progress and Financial Challenges

Via official filing (AI summary) | 7 months ago | 0 comments

11204
1
SpartanNash Co SpartanNash Reports Mixed Financial Results for 12 and 40 Weeks Ended October 5, 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11205
1
authID Inc. authID Inc. Reports Increased Cash and Assets, Revenue Growth, and Net Loss in Latest Quarter

Via official filing (AI summary) | 7 months ago | 0 comments

11206
1
Redfin Corp Redfin Reports Mixed Q3 2024 Results with 3% Revenue Growth and Net Loss

Via official filing (AI summary) | 7 months ago | 0 comments

11207
1
ACM Research, Inc. ACM Research Reports 21% Revenue Growth to $203.98M in Q3 2024, 44.2% Growth for Nine Months

Via official filing (AI summary) | 7 months ago | 0 comments

11208
1
CytomX Therapeutics, Inc. CytomX Therapeutics Reports 27% Revenue Growth, Net Income Improvement in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11209
1
Moderna, Inc. Moderna Reports Mixed Q3 Results, Net Income Turnaround, and FDA Approval for RSV Vaccine

Via official filing (AI summary) | 7 months ago | 0 comments

11210
1
EyePoint Pharmaceuticals, Inc. Eyepoint Pharmaceuticals Reports 31% Revenue Decline, Widened Losses in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11211
1
Viper Energy, Inc. Viper Energy Reports Significant Financial Developments in 10-Q Filing for Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11212
1
WOLVERINE WORLD WIDE INC /DE/ Wolverine World Wide Reports 16.6% Revenue Decline in Q3 2024, Net Earnings Increase 170%

Via official filing (AI summary) | 7 months ago | 0 comments

11213
1
AIR LEASE CORP Air Lease Corporation Reports Mixed Q3 Results with 4.7% Revenue Growth and Decreased Net Income

Via official filing (AI summary) | 7 months ago | 0 comments

11214
1
TEGNA INC TEGNA Reports 13% Revenue Growth, 71% Operating Income Increase in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11215
1
INTERNATIONAL TOWER HILL MINES LTD International Tower Hill Mines Ltd. Reports Slight Improvement in Net Loss, Focuses on Livengood Gold Project

Via official filing (AI summary) | 7 months ago | 0 comments

11216
1
Nutex Health, Inc. Nutex Health Reports 25.6% Revenue Growth, Net Loss in Latest Quarter

Via official filing (AI summary) | 7 months ago | 0 comments

11217
1
Kenvue Inc. Kenvue Inc. Reports Mixed Q3 and Nine-Month Results, Net Sales Down 0.4%

Via official filing (AI summary) | 7 months ago | 0 comments

11218
1
DENTSPLY SIRONA Inc. Dentsply Sirona Reports Mixed Q3 Results Amid Challenges, Announces Restructuring Initiatives

Via official filing (AI summary) | 7 months ago | 0 comments

11219
1
AXCELIS TECHNOLOGIES INC Axcelis Technologies Reports Decline in Financial Performance for Q3 and Nine Months of 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11220
1
e.l.f. Beauty, Inc. e.l.f. Beauty Reports 40% Revenue Growth, Net Sales Reach $301.1M in Latest Quarter

Via official filing (AI summary) | 7 months ago | 0 comments

11221
1
MERCADOLIBRE INC MercadoLibre Reports 37.6% Revenue Growth, Net Income Increase for Nine Months Ended September 30, 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11222
1
OLAPLEX HOLDINGS, INC. Olaplex Holdings Reports Decline in Financial Performance for Q3 and YTD 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11223
1
FOSTER L B CO L.B. Foster Reports Strong Profitability Recovery in Q3 2024 Despite Sales Decline

Via official filing (AI summary) | 7 months ago | 0 comments

11224
1
Aldeyra Therapeutics, Inc. Aldeyra Therapeutics Reports Significant Financial Challenges, Net Loss of $15.1M in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11225
1
PIPER SANDLER COMPANIES Piper Sandler Reports 23.6% Revenue Growth and Net Income Turnaround in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments